NCT03042780 2020-11-27
FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated
Clinical Trials
1 trialsPhase 2 × Gastro-enteropancreatic neuroendocrine tumor × Granulocyte Colony-Stimulating Factor × Clear all